STACEY RIPPLE: Open Payments
NPI 1336709799 · GRANVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 44 payments from 11 companies in 2025. Trend: 2023 $2,104 · 2024 $323 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $201 |
| ABBVIE INC. | 21 | $199 |
| Alkermes, Inc. | 4 | $84 |
| Lundbeck LLC | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, REXULTI, Auvelity, SPRAVATO, LYBALVI, Qelbree.
Industry payments across OH — which companies pay providers there.
